Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Connection

Search Results to Hedy Kindler

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Kindler, Hedy

Item TypeName
Concept Mesothelioma
Academic Article Gemcitabine for malignant mesothelioma: A phase II trial by the Cancer and Leukemia Group B.
Academic Article Edatrexate (10-ethyl-deaza-aminopterin) (NSC #626715) with or without leucovorin rescue for malignant mesothelioma. Sequential phase II trials by the cancer and leukemia group B.
Academic Article Malignant pleural mesothelioma.
Academic Article New approaches for mesothelioma: biologics, vaccines, gene therapy, and other novel agents.
Academic Article Phase II study of pemetrexed with and without folic acid and vitamin B12 as front-line therapy in malignant pleural mesothelioma.
Academic Article Capecitabine in malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B (39807).
Academic Article Semiquantitative analysis of dynamic contrast enhanced MRI in cancer patients: Variability and changes in tumor tissue over time.
Academic Article Moving beyond chemotherapy: novel cytostatic agents for malignant mesothelioma.
Academic Article Current state and future directions of pleural mesothelioma imaging.
Academic Article Response to the methylation inhibitor dihydro-5-azacytidine in mesothelioma is not associated with methylation of p16INK4a: results of cancer and leukemia group B 159904.
Academic Article The emerging role of pemetrexed for the treatment of malignant mesothelioma.
Academic Article Protein kinase C beta in malignant pleural mesothelioma.
Academic Article Measurement of mesothelioma on thoracic CT scans: a comparison of manual and computer-assisted techniques.
Academic Article Phase II trial of pemetrexed and gemcitabine in chemotherapy-naive malignant pleural mesothelioma.
Academic Article Pemetrexed plus gemcitabine as first-line chemotherapy for patients with peritoneal mesothelioma: final report of a phase II trial.
Academic Article Evaluation of semiautomated measurements of mesothelioma tumor thickness on CT scans.
Academic Article Antiangiogenic therapies for mesothelioma.
Academic Article Modeling of mesothelioma growth demonstrates weaknesses of current response criteria.
Academic Article Variability in mesothelioma tumor response classification.
Academic Article Functional analysis of c-Met/hepatocyte growth factor pathway in malignant pleural mesothelioma.
Academic Article Malignant pleural mesothelioma: an update on biomarkers and treatment.
Academic Article Preclinical studies of the proteasome inhibitor bortezomib in malignant pleural mesothelioma.
Academic Article Systemic treatments for mesothelioma: standard and novel.
Academic Article Malignant pleural mesothelioma.
Academic Article Phase I study of SS1P, a recombinant anti-mesothelin immunotoxin given as a bolus I.V. infusion to patients with mesothelin-expressing mesothelioma, ovarian, and pancreatic cancers.
Academic Article Quantitative measurement of lung reexpansion in malignant pleural mesothelioma patients undergoing pleurectomy/decortication.
Academic Article Update on malignant pleural mesothelioma.
Academic Article Cediranib in patients with malignant mesothelioma: a phase II trial of the University of Chicago Phase II Consortium.
Academic Article Robust data: the essential foundation of a revised staging system for pleural mesothelioma.
Academic Article A multicenter phase II study of cisplatin, pemetrexed, and bevacizumab in patients with advanced malignant mesothelioma.
Academic Article Erlotinib plus bevacizumab in previously treated patients with malignant pleural mesothelioma.
Academic Article Irinotecan for malignant mesothelioma A phase II trial by the Cancer and Leukemia Group B.
Academic Article Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma.
Academic Article A phase II study of sorafenib in malignant mesothelioma: results of Cancer and Leukemia Group B 30307.
Academic Article Current treatment options and biology of peritoneal mesothelioma: meeting summary of the first NIH peritoneal mesothelioma conference.
Academic Article Vatalanib in malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B (CALGB 30107).
Academic Article The cancer and leukemia group B respiratory committee.
Academic Article Optimization of response classification criteria for patients with malignant pleural mesothelioma.
Academic Article Role of protein kinase C ß and vascular endothelial growth factor receptor in malignant pleural mesothelioma: Therapeutic implications and the usefulness of Caenorhabditis elegans model organism.
Academic Article Sphingosine kinase 1 is required for mesothelioma cell proliferation: role of histone acetylation.
Academic Article Computerized segmentation and measurement of malignant pleural mesothelioma.
Academic Article Phase II study of dasatinib in patients with previously treated malignant mesothelioma (cancer and leukemia group B 30601): a brief report.
Academic Article Three-dimensional stereoscopic volume rendering of malignant pleural mesothelioma.
Academic Article High-dose doxorubicin, dexrazoxane, and GM-CSF in malignant mesothelioma: a phase II study-Cancer and Leukemia Group B 9631.
Academic Article The role of gemcitabine in the treatment of malignant mesothelioma.
Academic Article Gefitinib in patients with malignant mesothelioma: a phase II study by the Cancer and Leukemia Group B.
Academic Article Multicenter, double-blind, placebo-controlled, randomized phase II trial of gemcitabine/cisplatin plus bevacizumab or placebo in patients with malignant mesothelioma.
Academic Article Quality of life after radical pleurectomy decortication for malignant pleural mesothelioma.
Academic Article Utilisation of a thoracic oncology database to capture radiological and pathological images for evaluation of response to chemotherapy in patients with malignant pleural mesothelioma.
Academic Article Disease volumes as a marker for patient response in malignant pleural mesothelioma.
Academic Article Lung volume measurements as a surrogate marker for patient response in malignant pleural mesothelioma.
Academic Article MARS: a sense of perspective and an inconvenient truth.
Academic Article Peritoneal mesothelioma: the site of origin matters.
Academic Article MET and PI3K/mTOR as a potential combinatorial therapeutic target in malignant pleural mesothelioma.
Academic Article Phase II clinical trial of amatuximab, a chimeric antimesothelin antibody with pemetrexed and cisplatin in advanced unresectable pleural mesothelioma.
Academic Article Randomized phase II trial of pemetrexed/cisplatin with or without CBP501 in patients with advanced malignant pleural mesothelioma.
Academic Article Effects of extended pleurectomy and decortication on quality of life and pulmonary function in patients with malignant pleural mesothelioma.
Academic Article Variability of tumor area measurements for response assessment in malignant pleural mesothelioma.
Academic Article Radiologic-pathologic correlation of mesothelioma tumor volume.
Academic Article Vorinostat in patients with advanced malignant pleural mesothelioma who have progressed on previous chemotherapy (VANTAGE-014): a phase 3, double-blind, randomised, placebo-controlled trial.
Academic Article Extended Pleurectomy and Decortication for Malignant Pleural Mesothelioma Is an Effective and Safe Cytoreductive Surgery in the Elderly.
Academic Article Unique fractal evaluation and therapeutic implications of mitochondrial morphology in malignant mesothelioma.
Academic Article 208O_PR: CRS-207 with chemotherapy (chemo) in malignant pleural mesothelioma (MPM): Results from a phase 1b trial.
Academic Article Specimen weight and volume: important predictors of survival in malignant pleural mesothelioma.
Academic Article PI3 Kinase Pathway and MET Inhibition is Efficacious in Malignant Pleural Mesothelioma.
Academic Article A Multicenter Study of Volumetric Computed Tomography for Staging Malignant Pleural Mesothelioma.
Academic Article Immunological effects of the TGFß-blocking antibody GC1008 in malignant pleural mesothelioma patients.
Academic Article The IASLC Mesothelioma Staging Project: Proposals for the M Descriptors and for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Mesothelioma.
Academic Article Amount of Epithelioid Differentiation Is a Predictor of Survival in Malignant Pleural Mesothelioma.
Academic Article The Challenge of Defining Treatment Standards for a Rare Disease: Malignant Peritoneal Mesothelioma.
Academic Article The IASLC Mesothelioma Staging Project: Proposals for Revisions of the N Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Pleural Mesothelioma.
Academic Article The IASLC Mesothelioma Staging Project: Proposals for Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Pleural Mesothelioma.
Academic Article Validation of Progression-Free Survival as a Surrogate Endpoint for Overall Survival in Malignant Mesothelioma: Analysis of Cancer and Leukemia Group B and North Central Cancer Treatment Group (Alliance) Trials.
Academic Article A multicenter, double-blind, placebo-controlled randomized phase II trial of gemcitabine/cisplatin (GC) plus bevacizumab (B) or placebo in patients (pts) with malignant mesothelioma (MM).
Academic Article A phase 2 clinical trial of pemetrexed (P) plus gemcitabine (G) as front-line chemotherapy for patients with peritoneal mesothelioma (PM).
Academic Article Development of response criteria for mesothelioma based on a mathematical model.
Academic Article Influence of Pleurectomy and Decortication in Health-Related Quality of Life Among Patients with Malignant Pleural Mesothelioma.
Academic Article Integrative Molecular Characterization of Malignant Pleural Mesothelioma.
Academic Article Dynamic contrast-enhanced CT for the assessment of tumour response in malignant pleural mesothelioma: a pilot study.
Academic Article Current and Future Management of Malignant Mesothelioma: A Consensus Report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation.
Academic Article Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline Summary.
Academic Article Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline.
Academic Article Reply to D. de Fonseka et al.
Academic Article Frequency of Germline Mutations in Cancer Susceptibility Genes in Malignant Mesothelioma.
Academic Article Tremelimumab as second-line or third-line treatment in relapsed malignant mesothelioma (DETERMINE): a multicentre, international, randomised, double-blind, placebo-controlled phase 2b trial.
Academic Article Focal adhesion kinase a potential therapeutic target for pancreatic cancer and malignant pleural mesothelioma.
Academic Article Correlation of patient survival with clinical tumor measurements in malignant pleural mesothelioma.
Academic Article Maintenance Defactinib Versus Placebo After First-Line Chemotherapy in Patients With Merlin-Stratified Pleural Mesothelioma: COMMAND-A Double-Blind, Randomized, Phase II Study.
Academic Article Inherited predisposition to malignant mesothelioma and overall survival following platinum chemotherapy.
Academic Article A phase Ib study of GSK3052230, an FGF ligand trap in combination with pemetrexed and cisplatin in patients with malignant pleural mesothelioma.
Academic Article Clinical Response of Live-Attenuated, Listeria monocytogenes Expressing Mesothelin (CRS-207) with Chemotherapy in Patients with Malignant Pleural Mesothelioma.
Academic Article Reply to K. Masuda et al.
Academic Article Radiologic Considerations and Standardization of Malignant Pleural Mesothelioma Imaging Within Clinical Trials: Consensus Statement from the NCI Thoracic Malignancy Steering Committee - International Association for the Study of Lung Cancer - Mesothelioma Applied Research Foundation Clinical Trials Planning Meeting.
Academic Article EPHA2 mutations with oncogenic characteristics in squamous cell lung cancer and malignant pleural mesothelioma.
Academic Article EURACAN/IASLC Proposals for Updating the Histologic Classification of Pleural Mesothelioma: Towards a More Multidisciplinary Approach.
Academic Article Randomized Study of Maintenance Pemetrexed Versus Observation for Treatment of Malignant Pleural Mesothelioma: CALGB 30901.
Academic Article Malignant peritoneal mesothelioma: prognostic significance of clinical and pathologic parameters and validation of a nuclear-grading system in a multi-institutional series of 225 cases.
Academic Article Heterogeneity in PD-L1 expression in malignant peritoneal mesothelioma with systemic or intraperitoneal chemotherapy.
Academic Article Efficacy and safety of pembrolizumab in patients with advanced mesothelioma in the open-label, single-arm, phase 2 KEYNOTE-158 study.

Search Criteria
  • mesothelioma